Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Santangelo

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Neurology|June 27, 2021
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer's diseaseRoberto Santangelo, Federica Agosta, Francesco Masi, et al.
Neuroimage. Clinical|February 2, 2018
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohortSilvia Paola Caminiti, Tommaso Ballarini, Arianna Sala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 17, 2020
CSF p-tau/Aβ<sub>42</sub> ratio and brain FDG-PET may reliably detect MCI "imminent" converters to ADRoberto Santangelo, Federico Masserini, Federica Agosta, et al.
Current Alzheimer Research|July 27, 2019
The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's DementiaRoberto Santangelo, Alessandro Dell'Edera, Arianna Sala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2015
Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2015
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2014
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?Giovanni Di Maggio, Roberto Santangelo, Simone Guerrieri, et al.
Journal of Neurology|February 21, 2024
Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohortElisa Canu, Giulia Rugarli, Federico Coraglia, et al.
European Journal of Neurology|August 1, 2024
Analysis of individual alpha frequency in a large cohort from a tertiary memory centerGiordano Cecchetti, Federica Agosta, Elisa Canu, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease PatientsFerdinando Clarelli, Elisabetta Mascia, Roberto Santangelo, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Neurology|June 27, 2021
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer's diseaseRoberto Santangelo, Federica Agosta, Francesco Masi, et al.
Neuroimage. Clinical|February 2, 2018
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohortSilvia Paola Caminiti, Tommaso Ballarini, Arianna Sala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 17, 2020
CSF p-tau/Aβ<sub>42</sub> ratio and brain FDG-PET may reliably detect MCI "imminent" converters to ADRoberto Santangelo, Federico Masserini, Federica Agosta, et al.
Current Alzheimer Research|July 27, 2019
The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's DementiaRoberto Santangelo, Alessandro Dell'Edera, Arianna Sala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2015
Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2015
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2014
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?Giovanni Di Maggio, Roberto Santangelo, Simone Guerrieri, et al.
Journal of Neurology|February 21, 2024
Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohortElisa Canu, Giulia Rugarli, Federico Coraglia, et al.
European Journal of Neurology|August 1, 2024
Analysis of individual alpha frequency in a large cohort from a tertiary memory centerGiordano Cecchetti, Federica Agosta, Elisa Canu, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease PatientsFerdinando Clarelli, Elisabetta Mascia, Roberto Santangelo, et al.
Pageof 5